Login to Your Account

NPS Begins Teduglutide Pivotal Trial In Short-Bowel Syndrome

By Kim Coghill

Wednesday, April 7, 2004
NPS Pharmaceuticals Inc. initiated a pivotal Phase III study for the orphan product teduglutide, a potential treatment for short-bowel syndrome. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription